220 related articles for article (PubMed ID: 38212861)
1. Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status.
Reas ET; Triebswetter C; Banks SJ; McEvoy LK
Alzheimers Res Ther; 2024 Jan; 16(1):7. PubMed ID: 38212861
[TBL] [Abstract][Full Text] [Related]
2. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
[TBL] [Abstract][Full Text] [Related]
3. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
[TBL] [Abstract][Full Text] [Related]
4. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
5. White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease.
Adluru N; Destiche DJ; Lu SY; Doran ST; Birdsill AC; Melah KE; Okonkwo OC; Alexander AL; Dowling NM; Johnson SC; Sager MA; Bendlin BB
Neuroimage Clin; 2014; 4():730-42. PubMed ID: 24936424
[TBL] [Abstract][Full Text] [Related]
6. Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET.
Tato-Fernández C; Ekblad LL; Pietilä E; Saunavaara V; Helin S; Parkkola R; Zetterberg H; Blennow K; Rinne JO; Snellman A
Neurobiol Dis; 2024 Mar; 192():106439. PubMed ID: 38365046
[TBL] [Abstract][Full Text] [Related]
7. APOE effects on regional tau in preclinical Alzheimer's disease.
Young CB; Johns E; Kennedy G; Belloy ME; Insel PS; Greicius MD; Sperling RA; Johnson KA; Poston KL; Mormino EC; ;
Mol Neurodegener; 2023 Jan; 18(1):1. PubMed ID: 36597122
[TBL] [Abstract][Full Text] [Related]
8. Microstructural brain changes track cognitive decline in mild cognitive impairment.
Reas ET; Hagler DJ; White NS; Kuperman JM; Bartsch H; Wierenga CE; Galasko D; Brewer JB; Dale AM; McEvoy LK
Neuroimage Clin; 2018; 20():883-891. PubMed ID: 30290303
[TBL] [Abstract][Full Text] [Related]
9. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
Dunk MM; Driscoll I;
J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
[TBL] [Abstract][Full Text] [Related]
10. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
Vandal M; Alata W; Tremblay C; Rioux-Perreault C; Salem N; Calon F; Plourde M
J Neurochem; 2014 May; 129(3):516-26. PubMed ID: 24345162
[TBL] [Abstract][Full Text] [Related]
11. Effects of ApoE4 and ApoE2 genotypes on subcortical magnetic susceptibility and microstructure in 27,535 participants from the UK Biobank.
Nir TM; Zhu AH; Gari IB; Dixon D; Islam T; Villalon-Reina JE; Medland SE; Thompson PM; Jahanshad N
Pac Symp Biocomput; 2022; 27():121-132. PubMed ID: 34890142
[TBL] [Abstract][Full Text] [Related]
12. Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner.
Dratva MA; Banks SJ; Panizzon MS; Galasko D; Sundermann EE;
Biol Sex Differ; 2024 Jun; 15(1):45. PubMed ID: 38835072
[TBL] [Abstract][Full Text] [Related]
13. Opposing Effects of ApoE2 and ApoE4 on Glycolytic Metabolism in Neuronal Aging Supports a Warburg Neuroprotective Cascade against Alzheimer's Disease.
Zhang X; Wu L; Swerdlow RH; Zhao L
Cells; 2023 Jan; 12(3):. PubMed ID: 36766752
[TBL] [Abstract][Full Text] [Related]
14. Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals.
Yan S; Zheng C; Paranjpe MD; Li Y; Li W; Wang X; Benzinger TLS; Lu J; Zhou Y
Brain; 2021 Nov; 144(10):3201-3211. PubMed ID: 33876815
[TBL] [Abstract][Full Text] [Related]
15. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.
Sampedro F; Vilaplana E; de Leon MJ; Alcolea D; Pegueroles J; Montal V; Carmona-Iragui M; Sala I; Sánchez-Saudinos MB; Antón-Aguirre S; Morenas-Rodríguez E; Camacho V; Falcón C; Pavía J; Ros D; Clarimón J; Blesa R; Lleó A; Fortea J;
Oncotarget; 2015 Sep; 6(29):26663-74. PubMed ID: 26397226
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E2 Expression Alters Endosomal Pathways in a Mouse Model With Increased Brain Exosome Levels During Aging.
Peng KY; Liemisa B; Pasato J; D'Acunzo P; Pawlik M; Heguy A; Penikalapati SC; Labuza A; Pidikiti H; Alldred MJ; Ginsberg SD; Levy E; Mathews PM
Traffic; 2024 May; 25(5):e12937. PubMed ID: 38777335
[TBL] [Abstract][Full Text] [Related]
17. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.
Blautzik J; Kotz S; Brendel M; Sauerbeck J; Vettermann F; Winter Y; Bartenstein P; Ishii K; Rominger A;
J Alzheimers Dis; 2018; 65(3):781-791. PubMed ID: 28697560
[TBL] [Abstract][Full Text] [Related]
19. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy.
Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P
Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279
[TBL] [Abstract][Full Text] [Related]
20. Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.
Grothe MJ; Villeneuve S; Dyrba M; Bartrés-Faz D; Wirth M;
Neurology; 2017 Feb; 88(6):569-576. PubMed ID: 28062720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
